Champlain Investment Partners’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-697,285
Closed -$55.6M 146
2016
Q3
$55.6M Sell
697,285
-290,980
-29% -$23.5M 0.84% 42
2016
Q2
$77.1M Sell
988,265
-390,080
-28% -$27.8M 1.33% 17
2016
Q1
$75.8M Buy
1,378,345
+164,030
+14% +$8.94M 1.37% 14
2015
Q4
$75M Buy
1,214,315
+2,440
+0.2% +$154K 1.28% 19
2015
Q3
$76.5M Buy
1,211,875
+21,950
+2% +$1.57M 1.34% 15
2015
Q2
$86.9M Buy
1,189,925
+186,870
+19% +$13.5M 1.37% 15
2015
Q1
$65.6M Sell
1,003,055
-289,725
-22% -$19.3M 1.12% 24
2014
Q4
$84.1M Buy
1,292,780
+175,790
+16% +$11.3M 1.34% 17
2014
Q3
$67.2M Buy
1,116,990
+318,635
+40% +$20.8M 1.17% 20
2014
Q2
$55.3M Buy
798,355
+40,575
+5% +$2.63M 0.91% 38
2014
Q1
$49.6M Sell
757,780
-124,985
-14% -$8.14M 0.85% 48
2013
Q4
$54.7M Buy
882,765
+4,110
+0.5% +$238K 0.96% 33
2013
Q3
$47.1M Buy
878,655
+47,525
+6% +$2.45M 0.89% 42
2013
Q2
$37.9M Buy
+831,130
New +$36M 0.77% 53

Other funds holding STJ

Champlain Investment Partners's STJ Position: Q4 2016 in Review

Champlain Investment Partners sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 697,285 shares — an estimated $55.6M sold.

Champlain Investment Partners first reported a position in STJ in Q2 2013 and held it in 14 quarters. The position peaked at $86.9M in Q2 2015. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

  • Champlain Investment Partners reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
  • Champlain Investment Partners sold 697,285 St Jude Medical shares in Q4 2016, an estimated $55.6M.
  • Champlain Investment Partners first reported a position in St Jude Medical in Q2 2013 and held it in 14 quarters.
  • Champlain Investment Partners's St Jude Medical position peaked at $86.9M in Q2 2015.
  • 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on Champlain Investment Partners's 13F filing for Q4 2016, filed 13 Feb 2017.